The first dose is usually 1000 mcg (1 mg)
Taking BPC-157 acetate orally means losing approximately 97% of the dose to gastric degradation
Since detoxification pathways can be blocked in individuals with gut and autoimmune issues due to certain genetics and SNPs, it is important to boost glutathione to support these pathways, our DNA, and cells so the body is eliminating the toxins that can accumulate and contribute to leaky gut (or make it worse)
While recent incretin-based therapies have provided pharmaceutical inroads into treatment of obesity, there remains an ongoing need for additional medicines with distinct modes of action as independent or complementary therapeutics
V., Wang, Y., Witkowski, E
"Mutation spectrum of MMACHC in Chinese pediatric patients with cobalamin C disease: A case series and literature review"